美国食品和药物管理局数据库二次分析:操作性歇斯底里镜装置不良事件报告的差异
Arielle N Valdez-Sinon1, Anja S Frost2, Anita M Madison3
1Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Journal of minimally invasive gynecology
|May 8, 2025
概括
副作用报告揭示了透镜装置安全性的显著差异. 与切除镜相比,Morcellation设备的并发症和干预率更高,MyoSure报告的事件比TruClear更严重.
科学领域:
- 妇科手术手术是妇科手术.
- 医疗器械安全 医疗器械安全
- 通过透镜检查 (hysteroscopy) 进行透检查.
背景情况:
- 在妇科手术中,手术性透镜检查是常见的.
- 了解特定于设备的不良事件模式对于患者安全至关重要.
- 目前关于比较设备安全的现有数据有限.
研究的目的:
- 调查和比较常见的手术透镜设备的不良事件报告 (AER).
- 为了识别与不同透镜仪器相关的并发症和干预措施的模式.
主要方法:
- 美国食品和药物管理局MAUDE数据库的二次分析 (2014年1月至2024年4月).
- 包括对切除镜,MyoSure和TruClear歇斯底里镜体器的报道.
- 根据设备,患者并发症和干预措施对AER进行分类;使用费舍尔的精确测试进行分析.
主要成果:
- 确定了1872个AER:664个用于切除镜,1208个用于morcellator (MyoSure:645,TruClear:563).
- 据报道,切仪的出血率,子宫穿孔率和肠道穿孔率高于切除镜.
- 与TruClear AER相比,MyoSure AER报告了更严重的并发症和手术干预.
结论:
- 在操作性歇斯底里镜器件之间的AER存在显著差异.
- 摩塞拉装置报告的并发症和干预比切除镜更多.
- 与TruClear相比,MyoSure的严重并发症比例更高,突出了设备安全性和报告方面的潜在差异.
相关概念视频
Types of Reports II: Incident or Occurrence Report
1.3K
An Incident or Occurrence Report in a healthcare setting is a crucial document used to record any unexpected occurrence that may or may not have affected a patient, employee, or visitor. Such reports are critical to improving patient safety and include all details leading up to and including the event.
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
1.3K
Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Drug Products: Biologics, Biosimilars and Interchangeables
369
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
369
FDA Approved Drugs: Changes to Approved Drugs
343
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
343
Investigation of Disease Outbreaks
74
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
74


